Dextromethorphan Hydrobromide

CAS 6700-34-1 15 current records 5 historicalSmall Molecule

Who holds supplier records for Dextromethorphan Hydrobromide? 15 organisations hold a current record for Dextromethorphan Hydrobromide: an active US FDA Type II Drug Master File or a CEP. A further 5 organisations have only historical (inactive) DMF filings. 10 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (12) and China (2); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Dextromethorphan Hydrobromide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/dextromethorphan-hydrobromide

Reading the evidence

  • 15 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    12 of the 14 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 7 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (15)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Dextromethorphan Hydrobromide. Country is the organisation's recorded country, not necessarily the manufacturing site.

India12China2Country not recorded for 1
Need Dextromethorphan Hydrobromide sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (10)

Certificates of Suitability on the EDQM register for Dextromethorphan Hydrobromide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 14 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
ZHEJIANG APELOA KANGYU PHARMACEUTICAL CO., LTD. JinhuaCN
CEP 2021-026 - Rev 02
Dextromethorphan hydrobromide monohydrate
Nov 2026—
HY-GRO CHEMICALS PHARMTEK PRIVATE LIMITED SecunderabadIN
CEP 2014-023 - Rev 02
Dextromethorphan hydrobromide monohydrate
Oct 2026—
CHIFENG ARKER PHARMACEUTICAL TECHNOLOGY CO., LTD. ChifengCN
CEP 2019-218 - Rev 01
Dextromethorphan hydrobromide monohydrate
Aug 2026—
SRINI PHARMACEUTICALS PRIVATE LIMITED ChoutuppalIN
CEP 2018-201 - Rev 01
Dextromethorphan hydrobromide monohydrate
Jul 2026Inspected Sept 2025
Sweden
EXEMED PHARMACEUTICALS VadodaraIN
CEP 2021-257 - Rev 01
Dextromethorphan hydrobromide monohydrate
Feb 2026Inspected Feb 2025
Hungary
WANBURY LIMITED Vashi, Navi MumbaiIN
CEP 2022-268 - Rev 01
Dextromethorphan hydrobromide monohydrate
Oct 2025—
MALLADI DRUGS AND PHARMACEUTICALS LIMITED ReniguntaIN
CEP 2018-133 - Rev 02
Dextromethorphan hydrobromide monohydrate
Mar 2025—
SOLARA ACTIVE PHARMA SCIENCES LIMITED ChennaiIN
R1-CEP 2013-288 - Rev 00
Dextromethorphan hydrobromide monohydrate
Jun 2022—
DIVI'S LABORATORIES LIMITED HyderabadIN
R1-CEP 1999-103 - Rev 06
Dextromethorphan hydrobromide monohydrate
Jul 2018—
Wockhardt Limited MumbaiIN
R1-CEP 1998-053 - Rev 04
Dextromethorphan hydrobromide monohydrate
Mar 2017—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (5)

Organisations whose Type II DMFs for Dextromethorphan Hydrobromide are no longer active. These show a past filing, not current supply.

Show all 5 historical records
  • India · Inactive DMF 12467, 15560 · filed Jul 2001
  • STANDARD CHEM AND PHARM CO LTD
    Inactive DMF 13854 · filed Oct 1998
  • BILCHEM LTD
    Inactive DMF 8535 · filed Apr 1990
  • SIGMA F AND D DIV LTD
    Inactive DMF 7526 · filed Jun 1988
  • NYSCO LABS INC
    Inactive DMF 823 · filed Jul 1964

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Dextromethorphan Hydrobromide is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1256818).

Chemical identity

IUPAC name
(1S,9S,10S)-4-methoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene;hydrate;hydrobromide
Canonical SMILES
CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)OC.O.Br
InChIKey
STTADZBLEUMJRG-IKNOHUQMSA-N
Synonyms
Beecham coughcaps, Brontyl, Contac coughcaps, Delsym, Dextromethorphan hydrobromide, Dextromethorphan hydrobromide component of auvelity, Dextromethorphan hydrobromide component of avp-923, Dextromethorphan hydrobromide component of bromanate dm, Dextromethorphan hydrobromide component of bromfed-dm, Dextromethorphan hydrobromide component of dimetane-dx, Dextromethorphan hydrobromide component of mucinex dm, Dextromethorphan hydrobromide component of nuedexta

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Sigma-1 Agonist; Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Mechanism of action
Sigma-1 Receptor Agonists; Uncompetitive NMDA Receptor Antagonists

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Dextromethorphan Hydrobromide?

15 organisations hold an active US FDA Type II Drug Master File or a CEP for Dextromethorphan Hydrobromide: Divis Laboratories (India), Exemed Pharmaceuticals (India), HY-GRO CHEMICALS PHARMTEK PRIVATE LTD (India), MALLADI DRUGS AND PHARMACEUTICALS LTD (India), SOLARA ACTIVE PHARMA SCIENCES LTD (India), SRINI PHARMACEUTICALS PRIVATE LIMITED (India), WANBURY LTD (India) and Wockhardt Limited (India), and 7 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Dextromethorphan Hydrobromide Drug Master Files are active?

Divis Laboratories (DMF 12356), Exemed Pharmaceuticals (DMF 36112), HY-GRO CHEMICALS PHARMTEK PRIVATE LTD (DMF 33607), MALLADI DRUGS AND PHARMACEUTICALS LTD (DMF 32402), SOLARA ACTIVE PHARMA SCIENCES LTD (DMF 26762), SRINI PHARMACEUTICALS PRIVATE LIMITED (DMF 32848), WANBURY LTD (DMF 34241) and Wockhardt Limited (DMF 11935) and 6 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Dextromethorphan Hydrobromide records mean?

5 organisations have only inactive Type II DMFs for Dextromethorphan Hydrobromide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Dextromethorphan Hydrobromide have a European Certificate of Suitability?

Yes. 10 organisations hold a valid CEP for Dextromethorphan Hydrobromide on the EDQM register, including ZHEJIANG APELOA KANGYU PHARMACEUTICAL CO., LTD. Jinhua (CN), HY-GRO CHEMICALS PHARMTEK PRIVATE LIMITED Secunderabad (IN), CHIFENG ARKER PHARMACEUTICAL TECHNOLOGY CO., LTD. Chifeng (CN), SRINI PHARMACEUTICALS PRIVATE LIMITED Choutuppal (IN), EXEMED PHARMACEUTICALS Vadodara (IN) and WANBURY LIMITED Vashi, Navi Mumbai (IN) and 4 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Dextromethorphan Hydrobromide supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Dextromethorphan Hydrobromide?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.